Inventor · disambiguated record
Mark Gray-Keller
Also filed as: GRAY-KELLER MARK · GRAY-KELLER MARK P
10 granted patents·6 pending applications·63 citations·filing 2000–2010
87Inventor score
Files withXENON PHARMACEUTICALS INC5ATTIE ALAN D4WISCONSIN ALUMNI RES FOUND2XENON GENETICS INC2HAYDEN MICHAEL R1
Top patents by PatentIndex Score
16 records- 0190US7390813B1Pyridylpiperazines and aminonicotinamides and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2002·Granted Jun 24, 2008·35 cites·8 claims
- 0289US7790408B1Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agentsWISCONSIN ALUMNI RES FOUND·Filed 2005·Granted Sep 7, 2010·11 cites·3 claims
- 0381US6987001B2Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agentsUNIV BRITISH COLUMBIA·Filed 2001·Granted Jan 17, 2006·11 cites·11 claims
- 0474US7816075B2Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2005·Granted Oct 19, 2010·1 cites·7 claims
- 0566US6759208B2High throughput screening assays using fatty acid synthetic enzymesXENON GENETICS INC·Filed 2002·Granted Jul 6, 2004·3 cites·12 claims
- 0661US7863301B2Potentiators of insulin secretionWISCONSIN ALUMNI RES FOUND·Filed 2004·Granted Jan 4, 2011·0 cites·1 claims
- 0759US2009197894A1Nicotinamide derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 0858US7696151B2Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2005·Granted Apr 13, 2010·0 cites·8 claims
- 0956US7166584B1Cholesterol transport geneXENON GENETICS INC·Filed 2000·Granted Jan 23, 2007·2 cites·4 claims
- 1056US2007298420A1Cholesterol transport geneATTIE ALAN D·Filed 2006·Application pending·0 cites
- 1154US7294480B2High throughput screening assays using fatty acid synthetic enzymesXENON PHARMACEUTICALS INC·Filed 2004·Granted Nov 13, 2007·0 cites·13 claims
- 1252US2005119251A1Nicotinamide derivatives and their use as therapeutic agentsFiled 2004·Application pending·0 cites
- 1351US2011060014A1Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agentsHAYDEN MICHAEL R·Filed 2010·Application pending·0 cites
- 1448US8507557B2Potentiators of insulin secretionATTIE ALAN D·Filed 2010·Granted Aug 13, 2013·0 cites·4 claims
- 1537US2007065839A1Method of identifying agents to prevent or treat diabetesATTIE ALAN D·Filed 2006·Application pending·0 cites
- 1632US2008255064A1Methods for modulating cholecystokinin expressionATTIE ALAN D·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Gray-Keller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →